To our knowledge, this is the first systematic review and meta-analysis to comprehensively assess the diagnostic utility of INSM1 in distinguishing SCLC and LCNEC from other subtypes of NSCLC. This evidence concerns the gene INSM1 and large cell neuroendocrine carcinoma.